Skip to content

Clinical trials

Completed Triple Negative Breast Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Completed Country / region: Switzerland Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20101
20111
20151
20161
20172
20181
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Amgen1
Array Biopharma, now a wholly owned subsidiary of Pfizer1
Bayer1
Bristol-Myers Squibb1
ETOP IBCSG Partners Foundation1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms10
Pancreatic Neoplasms6
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Neoplasms2
Ovarian Neoplasms2
Biliary Tract Neoplasms1
Breast Diseases1
Cholangiocarcinoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.